Article Information
History
- October 20, 2017.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Tess Tsai-Hsiu Lu17#,
- Steffen Heyne1#,
- Erez Dror1,
- Eduard Casas2,3,4,
- Laura Leonhardt1,
- Thorina Boenke1,
- Chih-Hsiang Yang1,
- Sagar1,
- Laura Arrigoni1,
- Kevin Dalgaard17,
- Raffaele Teperino18,
- Lennart Enders1,
- Madhan Selvaraj17,
- Marius Ruf1,
- Sunil Jayaramaiah Raja1,
- Huafeng Xie5,
- Ulrike Boenisch1,
- Stuart H. Orkin5,
- Francis C Lynn6,
- Brad G. Hoffman6,
- Dominic Grün1,
- Tanya Vavouri2,3,
- Adelheid Lempradl1 and
- J. Andrew Pospisilik1,*
- 1Max Planck Institute of Immunobiology and Epigenetics, Stuebeweg 51, 79108 Freiburg, Germany
- 2Institute for Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Barcelona, Spain.
- 3Josep Carreras Leukaemia Research Institute (IJC), Can Ruti Campus, Badalona, Barcelona, Spain.
- 4Germans Trias i Pujol Health Sciences Research Institute (IGTP), Badalona, Barcelona, Spain.
- 5Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.
- 6Diabetes Research Program, Child and Family Research Institute, A4-184, 950 West 28 Ave, Vancouver, BC, V5Z 4H4, Canada.
- ↵*Correspondence to: pospisilik{at}ie-freiburg.mpg.de
↵# Equal contribution